Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Hospital Universitario 12 de Octubre, Servicio de Hematologia, Madrid

Mayo Clinic, Jacksonville

University of Miami Sylvester Comprehensive Cancer Center, Coral Gables

Salamanca University Hospital, Salamanca

University of Michigan Comprehensive Cancer Center, Ann Arbor

Mayo Clinic, Rochester

Washington University Medical Center, St Louis

Mayo Clinic, Scottsdale

Ronald Reagan UCLA Medical Center, Los Angeles

City of Hope National Medical Center, Duarte

Providence Portland Medical Center, Providence Cancer Center, Portland

University of Alabama Comprehensive Cancer Center, Birmingham

Yale Cancer Center, New Haven

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

University of Texas Southwestern Medical Center, Dallas

Institut Catala d'Oncologia (ICO) L'Hospitalet, L'Hospitalet de Llobregat

Fundacion Privada Instituto de Investigacion Oncologica de Vall Hebron, Barcelona